SCHEMBL30995035

SCHEMBL30995035

COc1cc(-c2c(N)ccc(Cl)c2F)ccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 2/20 0.45
▸ DYRK1A Q13627 3/20 0.43
▸ TDO2 P48775 1/20 0.41
▸ BACE1 P56817 1/20 0.40
▸ LOX P28300 1/20 0.39
▸ LOXL2 Q9Y4K0 1/20 0.39
▸ GRM2 Q14416 1/20 0.37
▸ ADORA2A P29274 2/20 0.37
▸ CNR1 P21554 1/20 0.37
▸ MAPK13 O15264 1/20 0.37
▸ MAPK12 P53778 1/20 0.37
▸ MAPK11 Q15759 1/20 0.37
▸ MAPK14 Q16539 1/20 0.37
▸ LRRK2 Q5S007 1/20 0.36
▸ GRM5 P41594 1/20 0.35
▸ GRM1 Q13255 1/20 0.35
▸ ACVR2A P27037 1/20 0.34
▸ TGFBR2 P37173 1/20 0.34
▸ GABRA1 P14867 1/20 0.34
▸ GABRG2 P18507 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12491503 0.78 CYP3A4 (0.53) ADORA2BDYRK1ATDO2BACE1LOX
SCHEMBL16013957 0.78 ADORA2B (0.46) ADORA2BDYRK1ATDO2BACE1LOX
SCHEMBL16971558 0.78 ALOX5AP (0.37) ADORA2BDYRK1ATDO2
SCHEMBL4279791 0.75 DYRK1A (0.43) ADORA2BDYRK1ABACE1ADORA2AS1PR1
SCHEMBL30296351 0.75 TDO2 (0.43) ADORA2BDYRK1ATDO2BACE1LOX
SCHEMBL24196194 0.75 KIT (0.47) DYRK1ATDO2BACE1LOXLOXL2
SCHEMBL31174103 0.74 F11 (0.40) ADORA2BDYRK1ATDO2GRM2GRM5
SCHEMBL23063240 0.74 LOX (0.42) DYRK1ALOXLOXL2ADORA2ACNR1
SCHEMBL18755256 0.73 LOX (0.45) ADORA2BDYRK1ABACE1LOXLOXL2
SCHEMBL30995101 0.72 CNR1 (0.47) DYRK1ATDO2BACE1LOXLOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4737457-A1 POLYSUBSTITUTED MACROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shenzhen Salubris Pharmaceuticals Co., Ltd. (CN) 2026-05-06 — — EP disclosed
CN-119894901-A Polysubstituted macrocyclic compound, and preparation method and application thereof 深圳信立泰药业股份有限公司 2025-04-25 — — CN disclosed
WO-2025002297-A1 POLYSUBSTITUTED MACROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 深圳信立泰药业股份有限公司 2025-01-02 — — WO disclosed
CN-118126046-A Substituted macrocyclic compound, and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-06-04 — — CN disclosed
Send feedback